Breaking news

Rapid Boost In European AI Adoption Highlights Cyprus’ Challenges

According to recent data from Eurostat, artificial intelligence adoption among European enterprises reached new heights in 2025. However, while the European Union continues to witness remarkable progress, Cyprus remains notably behind the continental average.

EU Growth Momentum

Across the bloc, approximately 20 percent of enterprises with at least 10 employees implemented AI technologies in 2025. This strong 6.5 percentage point increase from 13.5 percent in 2024 underscores the accelerating momentum among businesses in embracing digital tools to drive innovation and efficiency.

Cyprus’ Lagging Performance

Despite steady improvements over the past four years, Cyprus recorded an AI adoption rate of only 9.27 percent in 2025, significantly lower than the EU-27 average of 19.95 percent. This gap of more than 10 percentage points positions Cyprus just above countries like Greece, Bulgaria, Poland, Turkey (7.41 percent), and Romania, thereby highlighting a persistent challenge for Cypriot enterprises.

Historical Perspective And Comparative Analysis

In 2021, Cyprus’ AI adoption was a modest 2.59 percent, compared to an EU-27 average of 7.65 percent. Although by 2023 Cyprus had increased its rate to 4.67 percent—with the EU average at 8.06 percent—the disparity remained evident. By 2024, as the EU surged to 13.48 percent and Cyprus reached 7.90 percent, the performance gap widened further. In 2025, despite Cyprus more than tripling its 2021 rate, the divide continued to grow.

Country Leaders And Innovative Trends

The data reveals stark contrasts among EU nations. Leaders such as Denmark, Finland, and Sweden reported adoption rates of 42.0 percent, 37.8 percent, and 35.0 percent respectively. Meanwhile, nations like Romania (5.2 percent), Poland (8.4 percent), and Bulgaria (8.5 percent) trailed behind, with Cyprus falling just above these lower figures. Additionally, nearly all EU countries reported increases in AI usage, with Denmark, Finland, and Lithuania registering the most significant gains.

Key Applications Driving Adoption

The analysis further indicates that the most common application of AI was in analyzing written language, used by 11.8 percent of businesses. This was followed by generating multimedia content (9.5 percent), creating written or spoken language (8.8 percent), and converting spoken language into machine-readable formats (7.2 percent). Notably, the analysis of written language experienced the fastest growth compared to 2024, increasing by 4.9 percentage points.

This trend clearly demonstrates AI’s transition from a nascent technology to an integral component of business strategy across Europe, even as some markets like Cyprus continue to grapple with broader digital integration challenges.

Colossal Biosciences Seeks Funding At Up To $30 Billion Valuation

Colossal Biosciences, the biotechnology startup known for its efforts to revive extinct species including the woolly mammoth and dire wolf, is in talks to raise funding at a valuation of $20 billion to $30 billion, according to Axios.

The company was last valued at $10.2 billion in a January funding round. It has since begun generating revenue, Axios reported, although neither the size of the new financing nor its potential investors have been disclosed.

Business Extends Beyond De-Extinction

While Colossal has attracted global attention for its de-extinction projects, the company is also building a broader biotechnology business around the tools developed through that research.

Co-founder and Chief Executive Ben Lamm has said Colossal expects revenue from three areas: conservation technologies, new businesses created from its research and future commercial applications of technologies developed alongside its de-extinction programme.

Expanding Commercial Portfolio

Colossal has already supplied conservation technology to the U.S. government and the United Arab Emirates, which recently invested $60 million in the company, according to Wired.

Its research has also led to the creation of several startups, including plastics recycling company Breaking, computational biology platform Form Bio, which raised $30 million, and AI-driven biology company Astromech, which was valued at $2 billion in March.

Research Continues To Expand

Operating from a 55,000-square-foot facility in Dallas, Colossal continues to broaden its research portfolio.

In April, the company added the bluebuck antelope as its sixth de-extinction target. More recently, the Colossal Foundation partnered with the University of Tasmania to develop vaccines and gene-editing approaches aimed at protecting Tasmanian devils from a contagious facial cancer.

Lamm has also said the company plans to spin out its artificial womb technology, which could eventually have applications in fertility treatment. Speaking to Rolling Stone in May, he said the technology could be ready next year.

Investor Interest In Deep Tech

The fundraising discussions come as investors increase spending on sectors such as biotechnology, longevity and other deep-tech fields.

Lamm has also said Colossal could eventually generate revenue from biodiversity credits if restored species are successfully reintroduced into their natural habitats, creating another potential commercial opportunity.

eCredo
Aretilaw firm
The Future Forbes Realty Global Properties
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter